FAM186A: Potential Therapeutic Targets and Biomarkers (G121006)

Target Name: FAM186A

NCBI ID: G121006

FAM186A

Other Name(s): F186A_HUMAN | Family with sequence similarity 186 member A | Protein FAM186A | family with sequence similarity 186 member A

FAM186A: Potential Therapeutic Targets and Biomarkers

FAM186A (F186A_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the FAM186A gene family, which encodes a protein involved in the intracellular signaling pathway known as the TOR signaling pathway. This pathway is involved in various cellular processes, including cell growth, differentiation, and survival.

FAM186A is highly expressed in the liver, and is also expressed in other tissues such as the pancreas, spleen, and muscle. It is also found in the blood and lymph fluid. FAM186A is a glycoprotein, which means it consists of both protein and carbohydrate components.

The FAM186A protein is involved in various cellular processes, including cell signaling, inflammation, and metabolism. It is a key regulator of the TOR signaling pathway, which is a well-established pathway involved in the regulation of cell growth, differentiation, and survival.

FAM186A is highly expressed in various tissues of the human body, including the liver, pancreas, spleen, and muscle. It is also found in the blood and lymph fluid.

One of the well-established functions of FAM186A is its role in the regulation of cellular signaling. The TOR signaling pathway is a key regulator of cellular signaling, and FAM186A is involved in this pathway. It plays a key role in the regulation of cell growth, differentiation, and survival by controlling the activity of the TOR kinase.

FAM186A is also involved in the regulation of inflammation. It has been shown to be involved in the regulation of inflammation and immune responses.

FAM186A is also involved in metabolism. It has been shown to be involved in the regulation of glucose metabolism and insulin sensitivity.

FAM186A is a potential drug target and biomarker for various diseases. Its involvement in the TOR signaling pathway makes it a potential target for therapies aimed at modulating cellular signaling pathways. Additionally, its involvement in the regulation of cell growth, differentiation, and survival makes it a potential target for therapies aimed at modulating cell proliferation.

FAM186A is also a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its involvement in the regulation of cellular signaling pathways makes it a potential indicator of disease severity and response to therapeutic interventions.

In conclusion, FAM186A (F186A_HUMAN) is a protein that is involved in various cellular processes, including cell signaling, inflammation, and metabolism. Its involvement in the TOR signaling pathway makes it a potential target for therapies aimed at modulating cellular signaling pathways. Additionally, its involvement in the regulation of cell growth, differentiation, and survival makes it a potential target for therapies aimed at modulating cell proliferation. As a potential biomarker, FAM186A may be useful in the diagnosis and prognosis of various diseases.

Protein Name: Family With Sequence Similarity 186 Member A

The "FAM186A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM186A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets